Letko, Brosseau & Associates’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Hold |
24,700
| – | – | 0.01% | 76 |
|
|
2025
Q1 | $311K | Hold |
24,700
| – | – | 0.01% | 76 |
|
|
2024
Q4 | $261K | Hold |
24,700
| – | – | 0.01% | 89 |
|
|
2024
Q3 | $358K | Hold |
24,700
| – | – | 0.01% | 88 |
|
|
2024
Q2 | $210K | Sell |
24,700
-11,300
| -31% | -$96.2K | ﹤0.01% | 93 |
|
|
2024
Q1 | $368K | Hold |
36,000
| – | – | 0.01% | 87 |
|
|
2023
Q4 | $197K | Hold |
36,000
| – | – | ﹤0.01% | 88 |
|
|
2023
Q3 | $136K | Buy |
+36,000
| New | +$136K | ﹤0.01% | 90 |
|